2 events about "Teplizumab"

13 January 2026, 07:12

The European Commission has approved teplizumab, a new treatment for people with type 1 diabetes, at a stage of the disease where diabetes has not yet clinically manifested.

Sources

+2

Health

8 July 2025, 08:54

Teplizumab, a new drug, could delay the need for insulin for patients with type 1 diabetes by up to 3 years.

Sources

Health

Personalized news feed, AI-powered search, and notifications in a more interactive experience.

app preview

google play badge